Dipal Doshi - Insider Trading & Ownership

Location
C/O Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury, NJ
Summary
The estimated net worth of Dipal Doshi is at least $2.47M dollars as of September 4, 2025. Dipal Doshi is the CEO, Director of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $2.26M. Dipal Doshi is the Director of Azenta, Inc. and owns shares of Azenta, Inc. (AZTA) stock worth about $211K.
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Dipal Doshi

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRDA Entrada Therapeutics, Inc. CEO, Director $2.26M Sep 2, 2025
AZTA Azenta, Inc. Director $211K Feb 7, 2025

Insider Transactions Reported by Dipal Doshi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.